Last: | $4.27 |
---|---|
Change Percent: | -0.24% |
Open: | $4.2 |
Close: | $4.27 |
High: | $4.29 |
Low: | $4.19 |
Volume: | 295,390 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.27 | $4.2 | $4.27 | $4.29 | $4.19 | 295,390 | 07-03-2024 |
$4.19 | $4.21 | $4.19 | $4.23 | $4.15 | 908,076 | 07-02-2024 |
$4.16 | $4.19 | $4.16 | $4.22 | $4.13 | 738,268 | 07-01-2024 |
$4.28 | $4.36 | $4.28 | $4.38 | $4.2617 | 558,768 | 06-28-2024 |
$4.36 | $4.36 | $4.36 | $4.37 | $4.315 | 495,184 | 06-27-2024 |
$4.39 | $4.34 | $4.39 | $4.4 | $4.32 | 445,701 | 06-26-2024 |
$4.32 | $4.38 | $4.32 | $4.4 | $4.3 | 498,780 | 06-25-2024 |
$4.38 | $4.39 | $4.38 | $4.4088 | $4.345 | 723,467 | 06-24-2024 |
$4.37 | $4.4 | $4.37 | $4.41 | $4.35 | 938,136 | 06-21-2024 |
$4.38 | $4.38 | $4.38 | $4.415 | $4.3 | 549,663 | 06-20-2024 |
$4.44 | $4.37 | $4.44 | $4.45 | $4.37 | 520,472 | 06-19-2024 |
$4.44 | $4.37 | $4.44 | $4.45 | $4.37 | 520,472 | 06-18-2024 |
$4.35 | $4.39 | $4.35 | $4.4 | $4.3 | 1,022,178 | 06-17-2024 |
$4.51 | $4.5 | $4.51 | $4.52 | $4.435 | 494,249 | 06-14-2024 |
$4.51 | $4.6 | $4.51 | $4.6 | $4.5 | 331,693 | 06-13-2024 |
$4.61 | $4.69 | $4.61 | $4.69 | $4.575 | 536,049 | 06-12-2024 |
$4.57 | $4.55 | $4.57 | $4.58 | $4.49 | 489,693 | 06-11-2024 |
$4.59 | $4.57 | $4.59 | $4.61 | $4.555 | 427,410 | 06-10-2024 |
$4.51 | $4.6 | $4.51 | $4.6 | $4.4925 | 338,944 | 06-07-2024 |
$4.61 | $4.57 | $4.61 | $4.615 | $4.55 | 324,903 | 06-06-2024 |
News, Short Squeeze, Breakout and More Instantly...
Israel Chemicals Limited Company Name:
ICL Stock Symbol:
NYSE Market:
Israel Chemicals Limited Website:
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Delivers solid sequential quarterly improvement in sales of $1.7 billion and adjusted EBITDA of $362 million ICL (NYSE: ICL) (TASE: ICL) , a leading global specialty minerals company, today reported its financial results for the first quarter ended March 31, 2024. Consolidat...
ICL ( NYSE: ICL) (TASE: ICL ) , a leading global specialty minerals company, today announced Anantha Desikan, executive vice president and chief innovation and technology officer of ICL, will be presenting at 2024 BMO Global Farm to Market Conference at 11 a.m. ET on Thursday, May 16, 2024....